SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

76,515.43 362.57
( 0.48%)

Global Indices

Nasdaq

53,423.66 -283.45
(-0.53%)

Dow Jones

7,737.34 -31.37
(-0.40%)

Hang Seng

65,002.68 788.20
(1.23%)

Nikkei 225

10,828.70 -2.82
(-0.03%)

Forex

USD-INR

94.48 -0.24
(-0.26%)

EUR-INR

109.71 0.00
(0.00%)

GBP-INR

127.63 -0.19
(-0.15%)

JPY-INR

0.60 0.01
(1.60%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Ipca Laboratories Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

524494

INE571A01038

314.5139046

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

IPCALAB

39.38

49855.42

EPS(TTM)

Face Value()

Div & Yield %

49.9

0.31

Back

sharanam infraproject & trading ltd

Lupin consolidated net profit rises 16.08% in the June 2026 quarter

Aug 07,2026

Net profit of Lupin rose 16.08% to Rs 1415.00 crore in the quarter ended June 2026 as against Rs 1219.03 crore during the previous quarter ended June 2025. Sales rose 33.32% to Rs 8217.23 crore in the quarter ended June 2026 as against Rs 6163.75 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	8217.23	6163.75	33
OPM %	29.81	28.02	-
PBDT	2470.21	1714.52	44
PBT	2017.36	1415.54	43
NP	1415.00	1219.03	16

76,515.43 362.57 ( 0.48%)

53,423.66 -283.45 (-0.53%)

7,737.34 -31.37 (-0.40%)

65,002.68 788.20 (1.23%)

10,828.70 -2.82 (-0.03%)

94.48 -0.24 (-0.26%)

109.71 0.00 (0.00%)

127.63 -0.19 (-0.15%)

0.60 0.01 (1.60%)